John Burns
Director of Finance/CFO at SELLAS LIFE SCIENCES GROUP, INC.
Net worth: 94 352 $ as of 2024-03-30
Profile
John T.
Burns is currently the Chief Financial Officer & Accounting Officer, SVP at SELLAS Life Sciences Group, Inc. He previously worked as the Manager-Securities & Exchange Reporting at Pixelworks, Inc. and as the Chief Accounting Officer at Galena Biopharma, Inc. Mr. Burns completed his undergraduate and graduate degrees at Tulane University (Louisiana).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-21 | 93,418 ( 0.17% ) | 94 352 $ | 2024-03-30 |
John Burns active positions
| Companies | Position | Start |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Director of Finance/CFO | 2017-12-29 |
Former positions of John Burns
| Companies | Position | End |
|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | - |
Training of John Burns
| Tulane University (Louisiana) | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Stock Market
- Insiders
- John Burns
